Maximilien Levesque ^UDM

Maximilien Levesque, the CEO and co-founder of AQEMIA, is at the forefront of the company's mission to revolutionize drug discovery using quantum and statistical mechanics algorithms. AQEMIA stands out for its generative AI in designing novel drug candidates, with Maximilien's leadership being central to its groundbreaking work in the pharmaceutical industry.